Diabetes drug and exercise study pulled before starting
NCT ID NCT06438874
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study was designed to see if GLP-1 agonists (a type of diabetes medication) change how stiff arteries become after exercise in people with type 2 diabetes. Researchers planned to measure artery stiffness and blood pressure during a cycling test. However, the study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Exercise test (cycle ergometer) and GLP-1 agonist medication
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?